Cargando…
The clinical validity of miR-126 as a prognostic marker in epithelial ovarian cancer
Ovarian cancer is the leading cause of gynecological cancer related death in females worldwide. Our previous study demonstrated that decreased expression of microRNA (miR-126) promoted ovarian cancer angiogenesis and invasion by targeting VEGF-A. This study aimed to evaluate the clinical validity of...
Autores principales: | Liu, Lin, Han, Qing, Cai, Jing, Xiao, Man, Huang, Da, Cao, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981431/ https://www.ncbi.nlm.nih.gov/pubmed/36862865 http://dx.doi.org/10.1097/MD.0000000000033085 |
Ejemplares similares
-
Prognostic potential of miR-144 in various cancers: A meta-analysis
por: Jia, Chong-Yang, et al.
Publicado: (2022) -
Prognostic and clinicopathological significance of miR-638 in cancer patients: A meta-analysis
por: Hu, Lixia, et al.
Publicado: (2021) -
Predictive Value of Serum miR-10b, miR-29c, and miR-205 as Promising Biomarkers in Esophageal Squamous Cell Carcinoma Screening
por: Xu, Hang, et al.
Publicado: (2015) -
miR-126 and miR-126*: New Players in Cancer
por: Meister, Jeannette, et al.
Publicado: (2010) -
Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer
por: Wang, Di, et al.
Publicado: (2016)